Literature DB >> 19640637

Bid integrates intrinsic and extrinsic signaling in apoptosis induced by alpha-tocopheryl succinate in human gastric carcinoma cells.

Yan Zhao1, Ruisong Li, Wei Xia, Jiri Neuzil, Yuxia Lu, Haijin Zhang, Xiujuan Zhao, Xiaohua Zhang, Changhao Sun, Kun Wu.   

Abstract

The underlying mechanisms of alpha-tocopheryl succinate (alpha-TOS)-mediated apoptosis are not understood in detail, although the redox-silent vitamin E analog is a potent apoptogen and anti-cancer agent. Our previous studies showed the important role of Fas signaling in apoptosis induced by the mitocan. The objective of the present study was to investigate whether apoptosis triggered by alpha-TOS in gastric carcinomas cells involves both mitochondria- and death receptor-dependent pathways. alpha-TOS induced apoptosis and mitochondrial permeability transition in a concentration- and time-dependent manner. As a consequence, cytochrome c and the apoptosis-inducing factor were released and caspases were activated. Bax was translocated from the cytosol to mitochondria and Bid was cleaved into its truncated form, tBid. Knocking down Bid by RNAi and Fas antisense oligodeoxynucleotides resulted in a decreased release and cleavage. The results imply that Bid may serve as a critical integrating factor of the death receptor and mitochondrial pathway in alpha-TOS-mediated apoptosis. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640637     DOI: 10.1016/j.canlet.2009.06.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Breast cancer cells promote osteoblastic differentiation via Sema 3A signaling pathway in vitro.

Authors:  Wei-Wei Shen; Wu-Gui Chen; Fu-Zhou Liu; Xu Hu; Hong-Kai Wang; Ying Zhang; Tong-Wei Chu
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.

Authors:  A R M Ruhul Amin; Dongsheng Wang; Hongzheng Zhang; Shifang Peng; Hyung Ju C Shin; Johann C Brandes; Mourad Tighiouart; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

3.  Momordica charantia lectin exhibits antitumor activity towards hepatocellular carcinoma.

Authors:  Chris Zhiyi Zhang; Evandro Fei Fang; Hai-Tao Zhang; Li-Li Liu; Jing-Ping Yun
Journal:  Invest New Drugs       Date:  2014-09-09       Impact factor: 3.850

4.  Targeting essential pathways in trypanosomatids gives insights into protozoan mechanisms of cell death.

Authors:  Despina Smirlis; Michael Duszenko; Antonio Jiménez Ruiz; Effie Scoulica; Patrick Bastien; Nicolas Fasel; Ketty Soteriadou
Journal:  Parasit Vectors       Date:  2010-11-17       Impact factor: 3.876

5.  ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells.

Authors:  Diana Walluscheck; Angela Poehlmann; Roland Hartig; Uwe Lendeckel; Peter Schönfeld; Agnes Hotz-Wagenblatt; Kathrin Reissig; Khuloud Bajbouj; Albert Roessner; Regine Schneider-Stock
Journal:  J Cell Mol Med       Date:  2013-06-25       Impact factor: 5.310

Review 6.  Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy.

Authors:  Alex Lyakhovich; Matilde E Lleonart
Journal:  Oxid Med Cell Longev       Date:  2015-11-30       Impact factor: 6.543

7.  Inhibition of autophagy enhanced cobalt chloride‑induced apoptosis in rat alveolar type II epithelial cells.

Authors:  Yan Yu; Wanting Li; Liqin Ren; Chunyan Yang; Dongze Li; Xin Han; Yeying Sun; Changjun Lv; Fang Han
Journal:  Mol Med Rep       Date:  2018-06-22       Impact factor: 2.952

8.  VALD-3, a Schiff base ligand synthesized from o-vanillin derivatives, induces cell cycle arrest and apoptosis in breast cancer cells by inhibiting the Wnt/β-catenin pathway.

Authors:  Hongling Li; Chunyan Dang; Xiaohui Tai; Li Xue; Yuna Meng; Shuping Ma; Jing Zhang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.